Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 12 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	E7389 in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction				Phase II, Phase I				CCC-PHII-75 7435, NCI-7435, NCT00365157
	Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma				Phase II				UMCC 2005.145 NCT00393796
	Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-Naive Patients With Advanced/Metastatic Bladder Carcinoma				Phase II				0609001823 NCT00461851
	Gemcitabine, Paclitaxel, Doxorubicin, and Pegfilgrastim in Treating Patients With Metastatic or Unresectable Bladder Cancer or Urinary Tract Cancer and Kidney Dysfunction				Phase II				MDA-2005-0839 MDA-2005-0939, 2005-0839, 7341, NCT00478361
	Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma				Phase II				06-006 NCT00588666
	Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types				Phase II				CA182-026 NCT00633789
	Randomized Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer				Phase II				UMCC 2007.097 NCT00645593
	Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer				Phase II				2008-039 NCT00696007
	Gemcitabine and Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma				Phase II				07-168 NCT00714948
	Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium				Phase II				2007-0933 NCT00756639


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute